An analysis of some effects of ethanol on performance in a passive avoidance task.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 6812120)

Published in Psychopharmacology (Berl) on January 01, 1982

Authors

G Bammer, G B Chesher

Articles by these authors

A pilot study of naltrexone-accelerated detoxification in opioid dependence. Med J Aust (1999) 2.13

The atropine-resistance of the response to intrinsic nerve stimulation of the guinea-pig bladder. Br J Pharmacol Chemother (1965) 1.23

A hierarchy of strategies heroin-using mothers employ to reduce harm to their children. J Subst Abuse Treat (2000) 1.14

Telephone reminders are a cost effective way to improve responses in postal health surveys. J Epidemiol Community Health (2002) 1.11

The long-term impact of childhood sexual abuse in Australian women. Child Abuse Negl (1999) 1.07

The human toxicity of marijuana. Med J Aust (1994) 1.07

Facilitation of avoidance acquisition in the rat by ethanol and its abolition by alpha methyl p-tyrosine. Psychopharmacologia (1974) 1.07

A study of potential risk factors for sexual abuse in childhood. Child Abuse Negl (1997) 1.05

Non-fatal heroin overdoses. Med J Aust (1994) 0.96

'Sending the wrong signal': analysis of print media reportage of the ACT heroin prescription trial proposal, August 1997. Aust N Z J Public Health (2000) 0.96

Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity. Psychopharmacologia (1975) 0.95

Acetylcholine in extracts and perfusates of urinary bladder. J Pharm Pharmacol (1967) 0.94

The effect of cannabidiol, alone and in combination with ethanol, on human performance. Psychopharmacology (Berl) (1979) 0.94

Why? Who? How? Estimating numbers of illicit drug users: lessons from a case study from the Australian Capital Territory. Aust N Z J Public Health (1996) 0.93

The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice. Br J Pharmacol (1973) 0.92

Ethanol and delta9-tetrahydrocannabinol interactive effects on human perceptual, cognitive and motor functions. II. Med J Aust (1977) 0.89

The effect of (-) trans-delta9-tetrahydrocannabinol, alone and in combination with ethanol, on human performance. Psychopharmacology (Berl) (1979) 0.88

Release of adrenergic transmitter from terminal nerve plexus in artery. Agents Actions (1969) 0.88

The interaction of ethanol and delta9-tetrahydrocannabinol in man: effects on perceptual, cognitive and motor functions. Med J Aust (1976) 0.87

The ethics of experimental heroin maintenance. J Med Ethics (1993) 0.87

The relationship between childhood sexual abuse and alcohol abuse in women--a case-control study. Addiction (1998) 0.86

Drug use, binge drinking and attempted suicide among homeless and potentially homeless youth. Aust N Z J Psychiatry (1995) 0.86

The "nicotinic" and "muscarinic" receptors of the urinary bladder of the guinea-pig. J Pharm Pharmacol (1966) 0.85

The interaction between prostaglandin E1 and delta 9-tetrahydrocannabinol on intestinal motility and on the abdominal constriction response in the mouse. Psychopharmacologia (1976) 0.84

The arguments about RSI: an examination. Community Health Stud (1988) 0.84

Pharmacological investigations of neurotransmitter involvement in passive avoidance responding: a review and some new results. Neurosci Biobehav Rev (1982) 0.83

Footshock induced analgesia in mice: its reversal by naloxone and cross tolerance with morphine. Life Sci (1977) 0.82

Tolerance and cross tolerance with morphine resulting from physiological release of endogenous opiates. Life Sci (1982) 0.81

Effect of cannabinoids on the abdominal constriction response in mice: within cannabinoid interactions. Psychopharmacologia (1976) 0.81

The quasi-morphine withdrawal syndrome: effect of cannabinol, cannabidiol and tetrahydrocannabinol. Pharmacol Biochem Behav (1985) 0.81

Anticonvulsant effects of cannabinoids in mice: drug interactions within cannabinoids and cannabinoid interactions with phenytoin. Psychopharmacologia (1974) 0.81

Naloxone-induced contracture of ileum from stressed guinea pigs. Eur J Pharmacol (1979) 0.80

The effect of delta9-tetrahydrocannabinol on plasma concentrations of non-esterified fatty acids in the mouse. J Pharm Pharmacol (1976) 0.80

Intercannabinoid and cannabinoid-ethanol interactions on human performance. Psychopharmacology (Berl) (1980) 0.80

The intramural ganglia and chromaffin cells in guinea pig atria: an ultrastructural study. Cardiovasc Res (1974) 0.79

Interaction of delta9-tetrahydrocannabinol and cannabidiol on intestinal motility in mice. J Pharm Pharmacol (1974) 0.79

The painlessness of the long distance runner. Med J Aust (1979) 0.78

Physical dependence on physiologically released endogenous opiates. Life Sci (1982) 0.78

Naloxone has no effect on ethanol-induced impairment of psychomotor performance in man. Psychopharmacology (Berl) (1982) 0.78

The effect of delta9-tetrahydrocannabinol on brain amine concentration and turnover in whole rat brain and in various regions of the brain. J Pharm Pharmacol (1975) 0.77

Cimetidine and ranitidine. Lack of effect on the pharmacokinetics of an acute ethanol dose. J Clin Gastroenterol (1993) 0.77

The influence of analgesic drugs in road crashes. Accid Anal Prev (1985) 0.76

The effect of withdrawal from cannabis on pentylenetetrazol convulsive threshold in mice. Psychopharmacologia (1974) 0.76

The attenuation of delta 9-tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats. Psychopharmacology (Berl) (1979) 0.76

Interaction of cannabis and general anaesthetic agents in mice. Br J Pharmacol (1974) 0.75

Interaction of delta9-tetrahydrocannabinol and cannabidiol with phenobarbitone in protecting mice from electrically induced convulsions. J Pharm Pharmacol (1975) 0.75

Alpha-noradrenergic modulation of hypothalamic self-stimulation: studies employing clonidine, 1-phenylephrine and alpha-methyl-p-tyrosine. Eur J Pharmacol (1976) 0.75

The effect of ethanol on a passive avoidance task in rats [proceedings]. Br J Pharmacol (1977) 0.75

Possible central dopaminergic modulation of the rise in plasma concentration of non-esterified fatty acids produced in the mouse by (-)trans-delta9-tetrahydrocannabinol. Biochem Pharmacol (1978) 0.75

[3H]Leu-enkephalin binding following chronic swim-stress in mice. Neurosci Lett (1983) 0.75

The effect of delta9-tetrahydrocannabinol, cannabidiol and cannabinol on ether anaesthesia in mice. J Pharm Pharmacol (1975) 0.75

No evidence for a protracted change in endogenous opioid activity following chronic opiate treatment in mice: parallel recovery of cross tolerance to stress and morphine antinociception. Psychopharmacology (Berl) (1984) 0.75

"They should have them all over the place": a health program for children of illicit drug users. Subst Use Misuse (2000) 0.75

The Australian High and Low avoidance rat strains: differential effects of ethanol and alpha-methyl-p-tyrosine. Behav Brain Res (1983) 0.75

The effect of amphetamine and tyramine on the guinea-pig urinary bladder. Agents Actions (1970) 0.75

Method of sacrifice influences leucine enkephalin binding to mouse brain. Pharmacol Biochem Behav (1981) 0.75

Some pharmacological aspects of drug dependence. Med J Aust (1975) 0.75

Swim-induced grooming in mice is mediated by a dopaminergic substrate. J Neural Transm (1981) 0.75

Australian reports into drug use and the possibility of heroin maintenance. Drug Alcohol Rev (1992) 0.75

(-)Trans-delta 9-tetrahydrocannabinol: synaptosomal phospholipids, synaptosomal plasma membrane (Na+-K+)-ATPase, and thiopentone anaesthesia in mice. Adv Biosci (1980) 0.75

The correlation between swim-stress induced antinociception and [3H] leu-enkephalin binding to brain homogenates in mice. Pharmacol Biochem Behav (1981) 0.75

Letters to the editor. Drug Alcohol Rev (1991) 0.75

delta9-Tetrahydrocannabinol and the quasi morphine withdrawal syndrome. Adv Biosci (1980) 0.75

The effect of delta 9-tetrahydrocannabinol, cannabidiol, and cannabinol on the anaesthesia induced by various anaesthetic agents in mice. Psychopharmacology (Berl) (1977) 0.75

Is cardiac excitation in the heart of the mollusc Tapes watlingi cholinergic? Comp Biochem Physiol (1968) 0.75

The 'heroin trial', abstinence and community expectations. Drug Alcohol Rev (1995) 0.75

The human toxicity of marijuana: a critique of a review by Nahas and Latour. Drug Alcohol Rev (1994) 0.75

Biphasic dose-response relationship with acetylcholine on the heart of the mollusc Tapes turgida. Nature (1965) 0.75

Increased release of noradrenaline from pulmonary artery after a period of high frequency stimulation. Eur J Pharmacol (1974) 0.75

Differentiation of receptors for exogenous and endogenous acetylcholine in the urinary bladder. Agents Actions (1970) 0.75

Patterns of heroin use in the methadone programme in Sydney, 1986-1987. Drug Alcohol Rev (1990) 0.75

Post-swim grooming in mice inhibited by dopamine receptor antagonists and by cannabinoids. Pharmacol Biochem Behav (1980) 0.75

Multiple drug use by older people: exploring the health development and political economy perspectives. Drug Alcohol Rev (1993) 0.75